
    
      This is an ascending dose study evaluating the cardiovascular safety of dexmedetomidine
      bolus/infusions in acutely burned pediatric patients. The study entails a bolus of
      dexmedetomidine, followed by 2 hours of increasing infusion doses. Cardiovascular parameters
      including EKG, heart rate, oxygen saturation, blood pressure, are recorded.
    
  